Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular response to double-stranded RNA.

D S Haines1, K I Strauss, D H Gillespie

  • 1Department of Neoplastic Diseases, Hahnemann University, Philadelphia, Pennsylvania 19102.

Journal of Cellular Biochemistry
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis.

Oncogene·2010
Same author

Retraction for D. R. Zweitzig, N. Shcherbik, and D. S. Haines: AAA ATPase P97 and adaptor UBXD1 suppress MDM2 ubiquitination and degradation and promote constitutive P53 turnover.

Molecular biology of the cell·2008
Same author

Assignment of the MDM2 binding protein gene (MTBP) to human chromosome band 8q24 by in situ hybridization.

Cytogenetics and cell genetics·2000
Same author

MDM2 interacts with the C-terminus of the catalytic subunit of DNA polymerase epsilon.

Nucleic acids research·2000
Same author

Prolonged cyclooxygenase-2 induction in neurons and glia following traumatic brain injury in the rat.

Journal of neurotrauma·2000
Same author

A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2.

The Journal of biological chemistry·2000
Same journal

Tricarboxylic Acid (TCA) Cycle Enzyme Alpha-Ketoglutarate Dehydrogenase (KGDH) as a Nexus for the Regulation of Macrophage Polarization.

Journal of cellular biochemistry·2026
Same journal

Zinc Finger Proteins as Regulators of Organ Fibrosis.

Journal of cellular biochemistry·2026
Same journal

Intrinsic Disorder Status in Human Proteins Interacting With SARS-CoV-2 Proteins: Insights From Five Years of Translational Research.

Journal of cellular biochemistry·2026
Same journal

The Effect of Protein Tagging on Aggregation and Phase Separation.

Journal of cellular biochemistry·2026
Same journal

TRIM32 Alleviates the Inflammation in Spinal Cord Injury Progression Through Inducing the Ubiquitination Degradation of TLR4.

Journal of cellular biochemistry·2026
Same journal

Bedaquiline Binding at the Leading Site of Mycobacterium tuberculosis ATP Synthase Induces Distinct Structural and Dynamic Changes.

Journal of cellular biochemistry·2026
See all related articles

Double-stranded RNA (dsRNA) research advances understanding of gene regulation and immune responses. Synthetic dsRNA shows promise for treating cancer, HIV-1, and immune disorders, with potential for broader clinical use.

Area of Science:

  • Molecular Biology
  • Immunology
  • Virology
  • Oncology

Background:

  • Double-stranded RNA (dsRNA) plays a crucial role in cellular processes.
  • Basic research has elucidated dsRNA's involvement in gene induction, tumor suppression, and immune modulation.
  • Understanding dsRNA mechanisms is key to therapeutic development.

Purpose of the Study:

  • To explore the diverse roles of double-stranded RNA (dsRNA) in biological systems.
  • To highlight the therapeutic potential of synthetic dsRNA in clinical settings.
  • To underscore the importance of continued research into dsRNA mechanisms for future applications.

Main Methods:

  • Literature review of basic and clinical research on dsRNA.
  • Analysis of dsRNA's impact on gene expression and cellular functions.

Related Experiment Videos

  • Investigation of clinical applications of synthetic dsRNA.

    • Main Results:

    • dsRNA is implicated in gene induction, cancer cell growth arrest, antiviral defense, and immunomodulation.
    • Synthetic dsRNA is being investigated for treating cancer, HIV-1, and immune dysfunction.
    • Ongoing research continues to reveal new therapeutic possibilities for dsRNA.

    Conclusions:

    • Double-stranded RNA (dsRNA) has broad implications in basic science and medicine.
    • Synthetic dsRNA represents a promising therapeutic modality for various diseases.
    • Further research into dsRNA mechanisms will likely expand its clinical utility.